Publicaciones en colaboración con investigadores/as de Beckman Research Institute (2)

2023

  1. Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma

    Oncologist, Vol. 28, Núm. 1, pp. 59-71

2022

  1. Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial

    European Urology, Vol. 82, Núm. 3, pp. 283-292